1. Academic Validation
  2. Targeted Isolation of Anti-inflammatory Lignans from Justicia aequilabris by Molecular Networking Approach

Targeted Isolation of Anti-inflammatory Lignans from Justicia aequilabris by Molecular Networking Approach

  • J Nat Prod. 2022 Sep 23;85(9):2184-2191. doi: 10.1021/acs.jnatprod.2c00478.
Joanda P R E Silva 1 Laiane C O Pereira 1 Lucas S Abreu 2 Francisca S V Lins 1 Thalisson A de Souza 1 Renan F do Espírito-Santo 3 Renata P C Barros 1 Cristiane F Villarreal 4 José I M de Melo 1 Marcus T Scotti 1 Vicente C de O Costa 1 Lucas H Martorano 2 Fernando M Dos Santos Jr 2 Raimundo Braz Filho 5 Marcelo S da Silva 1 Josean F Tavares 1
Affiliations

Affiliations

  • 1 Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa 58037, Brazil.
  • 2 Department of Chemistry, Institute of Chemistry, Fluminense Federal University, Niterói 24220-008, Brazil.
  • 3 Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador 40015, Brazil.
  • 4 School of Pharmacy, Federal University of Bahia, Salvador 41500-290, Brazil.
  • 5 Department of Chemistry, Institute of Chemistry, Federal Rural University of Rio de Janeiro, Seropédica 23890, Brazil.
Abstract

Herein, the isolation of secondary metabolites from the aerial parts of Justicia aequilabris guided by HPLC-MSn and molecular networking analyses is reported. Twenty-two known compounds were dereplicated. Three new Lignans (aequilabrines A-C (1-3)) and three known compounds (lariciresinol-4'-O-β-glucose (4), roseoside (5), and allantoin (6)) were obtained. The anti-inflammatory activity of compounds 1-3 was evaluated in vitro by inhibiting the nitric oxide production (NO) and pro-inflammatory activity on the cytokine IL-1β. Compounds 2 and 3 showed significant inhibitory activity against NO production, with IC50 values of 9.1 and 7.3 μM, respectively. The maximum inhibition of IL-1β production was 23.5% (1), 27.3% (2), and 32.5% (3).

Figures